| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,453 | 1,965 | 1,275 | 534 |
| Trade accounts receivable, net | 3,027 | 2,926 | 2,828 | 2,815 |
| Inventories | 3,117 | 2,943 | 2,921 | 2,861 |
| Prepaid income taxes | 358 | 299 | 310 | 298 |
| Other current assets | 729 | 660 | 701 | 613 |
| Total current assets | 8,684 | 8,794 | 8,035 | 7,121 |
| Property, plant and equipment, net | 4,063 | 4,036 | 3,795 | 3,461 |
| Goodwill | 18,536 | 18,282 | 18,214 | 18,076 |
| Other intangible assets, net | 7,060 | 7,019 | 7,162 | 7,260 |
| Deferred tax assets | 3,953 | 3,675 | 3,669 | 3,778 |
| Restricted cash equivalents included in other long-term assets | NaN | NaN | 103 | 98 |
| Operating lease, right-of-use asset | NaN | NaN | 495 | 492 |
| Investments | NaN | NaN | 643 | 626 |
| Indemnification asset | NaN | NaN | 212 | 206 |
| Other, other long-term assets | NaN | NaN | 380 | 442 |
| Other long-term assets | 2,054 | 1,866 | 1,832 | 1,864 |
| Total assets | 44,351 | 43,673 | 42,707 | 41,559 |
| Current debt obligations | 41 | 299 | 483 | 480 |
| Accounts payable | 1,141 | 1,144 | 1,002 | 962 |
| Accrued expenses | 2,514 | 3,201 | 2,981 | 2,797 |
| Other current liabilities | 875 | 795 | 862 | 952 |
| Total current liabilities | 4,571 | 5,439 | 5,328 | 5,190 |
| Long-term debt | 10,988 | 11,137 | 11,117 | 11,107 |
| Deferred tax liabilities | 219 | 220 | 242 | 226 |
| Other long-term liabilities | 2,469 | 2,405 | 2,390 | 2,383 |
| Common stock, 0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of march31, 2026 and 1,746,290,165 shares issued as of december31, 2025 | 17 | 17 | 17 | 17 |
| Treasury stock, at cost - 263,289,848 shares as of march31, 2026 and december31, 2025 | 2,251 | 2,251 | 2,251 | 2,251 |
| Additional paid-in capital | 21,584 | 21,505 | 21,419 | 21,230 |
| Retained earnings | 6,912 | 5,571 | 4,899 | 4,144 |
| Accumulated other comprehensive income (loss), net of tax | -398 | -610 | -689 | -722 |
| Total stockholders equity | 25,864 | 24,233 | 23,394 | 22,418 |
| Noncontrolling interests | 240 | 239 | 236 | 235 |
| Total equity | 26,104 | 24,472 | 23,630 | 22,653 |
| Total liabilities and equity | 44,351 | 43,673 | 42,707 | 41,559 |
BOSTON SCIENTIFIC CORP (BSX)
BOSTON SCIENTIFIC CORP (BSX)